Loading…
Wednesday, May 15 • 11:30am - 12:15pm
Panel: Navigating Financial Communications and Investor Relations

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
  • Review the unique landscape of financial communications in the sector and understand the critical role of investor relations in shaping external perceptions
  • Explore strategies for aligning financial messages with the company's broader narrative and goals learn to articulate financial information in a clear, concise, and compelling manner
  • Outline the regulatory requirements governing financial communications in the pharmaceutical industry and establish best practices for transparent and compliant disclosures
  • Discover strategies for engaging with diverse stakeholders, including investors, analysts, and financial media and understand the nuances of tailoring financial communications for different audience segments
  • Gain insights into best practices for presenting financial results and making announcements and how to maintain effective investor relations during periods of market uncertainty the challenges of balancing transparency with strategic communication
  • Delve into key performance indicators (KPIs) for measuring the impact of financial communications and how to gauge and shape investor perceptions over time
Moderators
avatar for Lynnea Olivarez

Lynnea Olivarez

Founder & Community Manager, Ticket to Biotech
Lynnea Olivarez is a savvy life science communicator with experience spanning industry, agency and government. She recently founded the global biopharma communicator community Ticket to Biotech (T2B) after 15 years driving impactful communications across the drug development lifecycle... Read More →

Speakers
avatar for Tyler Marciniak, MSc, MBA

Tyler Marciniak, MSc, MBA

VP of Investor Relations, Corporate Communications & Advocacy, ACELYRIN, INC
Over a biopharma career spanning more than 20 years and multiple continents, Tyler has developed a strong track record of establishing and leading high performing teams in investor relations, corporate communications and stakeholder engagement, including patient advocacy and industry/government... Read More →
avatar for Eamonn Nolan

Eamonn Nolan

Senior Director, Corporate Communications & Investor Relations, MorphoSys
Eamonn is a strategic communications and investor relations leader with extensive experience across the pharmaceutical, biotech and healthcare non-profit sectors. He specializes in advising C-Suite leadership, building corporate reputation, promoting a company’s value proposition... Read More →
avatar for Greg Mann

Greg Mann

Senior Vice President, Public Affairs and Investor Relations, Nkarta
Greg Mann oversees and supports Nkarta’s corporate strategy and leads the corporate affairs function with a focus on engaging Nkarta’s stakeholders across patient and caregiver communities, clinical investigators, media, and investors. Greg has worked for more than 25 years in... Read More →
avatar for Michael Levey

Michael Levey

Director, Global Media Relations, Merck
Michael is a corporate communications leader with more than two decades of in-house and agency experience in the biopharmaceutical and medical device industries. He has a proven track record in leading integrated communications plans and media engagement strategies that drive measurable... Read More →

Wednesday May 15, 2024 11:30am - 12:15pm PDT
Grand Ballroom (A) Balboa Bay Resort | 1221 West Coast Hwy Newport Beach, CA 92663
  • QTAG featuredsessionv2